AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
AMP-activated protein kinase (AMPK) senses changes in the intracellular AMP/ATP ratio, switching off energy-consuming processes and switching on catabolic pathways in response to energy depletion. Here, we show that AMPK down-regulates rRNA synthesis under glucose restriction by phosphorylating the RNA polymerase I (Pol I)-associated transcription factor TIF-IA at a single serine residue (Ser-635). Phosphorylation by AMPK impairs the interaction of TIF-IA with the TBP-containing promoter selectivity factor SL1, thereby precluding the assembly of functional transcription initiation complexes. Mutation of Ser-635 compromises down-regulation of Pol I transcription in response to low energy supply, supporting that activation of AMPK adapts rRNA synthesis to nutrient availability and the cellular energy status.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it also directly suppresses ribosomal RNA synthesis”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [61]
In the citing paper
“AMPK can inhibit RNA polymerase I activity through multiple mechanisms, including suppression of TIF-1A function and modulation of chromatin accessibility at rDNA loci”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [61]
In the citing paper
“In HEK293T cells, glucose deprivation-induced AMPK activation has been reported to lead to increased phosphorylation of the RNA polymerase I-associated transcription factor TIF-IA at Ser635 (Hoppe et al., 2009).”
From Skeletal Muscle Ribosome and Mitochondrial Biogenesis in Response to Different Exercise Training Modalities (2021) · cites this paper as Hoppe et al., 2009
In the citing paper
“This phosphorylation event reduced the interaction of TIF-IA with other transcription factors and ultimately reduced the assembly of functional transcription initiation complexes at the rDNA promoter.”
From Skeletal Muscle Ribosome and Mitochondrial Biogenesis in Response to Different Exercise Training Modalities (2021) · cites this paper as Hoppe et al., 2009
Citations
Cites
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914 · cited 2×
“Consistent with a functional cross-talk between AMPK and mTOR (20, 21), phosphorylation of Ser-199 (spot a), D”
BackgroundAMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849 · cited 2×
“Consistent with a functional cross-talk between AMPK and mTOR (20, 21), phosphorylation of Ser-199 (spot a), D”
BackgroundKahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799 · cited 1×
“AMP-activated protein kinase (AMPK) plays a crucial role in translating changes in energy levels into adaptive cellular responses (1, 2).”
BackgroundAMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
Hardie, D. G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2249 · Cited by 2,216 · cited 2×
“AMPK targets multiple proteins ranging from key metabolic enzymes to transcription and translation factors (26).”
BackgroundAMP-activated protein kinase induces a p53-dependent metabolic checkpoint
Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., & Thompson, C. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.027 · Cited by 1,619 · cited 1×
“AMPK serves important functions in the nucleus, modulating the activity of specific transcriptions factors and coregulators, such as HNF4a (6), ChRBP (7), p53 (8), and p27 (9).”
BackgroundHawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589
Woods, A., Dickerson, K., Heath, R., Hong, S.-P., Momcilovic, M., Johnstone, S. R., Carlson, M., & Carling, D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.005 · Cited by 1,392
The AMP‐Activated Protein Kinase: Fuel Gauge of the Mammalian Cell?
Hardie, D. G., & Carling, D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00259.x · Cited by 1,317
Hawley, S. A., Davison, M., Woods, A., Davies, S. P., Beri, R. K., Carling, D., & Hardie, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27879 · Cited by 1,264 · cited 1×
“The drop of cellular ATP and concomitant increase in AMP levels triggered phosphorylation-dependent activation of AMPK at Thr-172 (17), suggesting that AMPK down-regulates pre-rRNA synthesis by targeting component(s) of the Pol I transcription machinery (Fig.”
BackgroundCorton, J. M., Gillespie, J. G., Hawley, S. A., & Hardie, D. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0558k.x · Cited by 1,230
Research works printed but not linked: 1
- 10.1111/j.1432-1033.1995.tb20498.x · doi:10.1111/j.1432-1033.1995.tb20498.x · Paper page
Cited by
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
“(regulators of the target of rapamycin (TOR) kinase, which promotes protein synthesis) and transcription initiation factor IA (TIFIA; also known as RRN3”
AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance
Garcia, D., & Shaw, R. J. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.032 · Cited by 1,978
AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function
Hardie, D. G. (2011) · Genes & Development · doi:10.1101/gad.17420111 · Cited by 1,638
“…glycerol phosphate acyl transferase (although it is not clear whether this is a direct substrate), glycogen synthesis by phosphorylation of glycogen synthase, and ribosomal RNA synthesis by phosphorylation of the RNA polymerase I transcription factor TIF-1A (RRN3) (Hardie 2007; Hoppe et al. 2009).”
BackgroundRegulation and function of AMPK in physiology and diseases
Jeon, S.-M. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.81 · Cited by 1,113
Boulon, S., Westman, B. J., Hutten, S., Boisvert, F.-M., & Lamond, A. I. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.024 · Cited by 1,103
AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs
Hardie, D. G., Schaffer, B. E., & Brunet, A. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.013 · Cited by 859
AMPK activators: mechanisms of action and physiological activities
Kim, J., Yang, G., Kim, Y., Kim, J., & Ha, J. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.16 · Cited by 817
AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control
González, A., Hall, M. N., Lin, S.-C., & Hardie, D. G. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.015 · Cited by 797
AMPK and mTOR in Cellular Energy Homeostasis and Drug Targets
Inoki, K., Kim, J., & Guan, K.-L. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134537 · Cited by 791
Ribosomal proteins: functions beyond the ribosome
Zhou, X., Liao, W.-J., Liao, J.-M., Liao, P., & Lu, H. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv014 · Cited by 743
“In line with this, a downstream target of the TOR pathway, AMP-activated protein kinase (AMPK), can be activated upon glucose deprivation to phosphorylate and inactivate TIF-IA, leading to the repression of RNA Pol I-mediated transcription (Hoppe et al., 2009).”
BackgroundAMPK at the Nexus of Energetics and Aging
Burkewitz, K., Zhang, Y., & Mair, W. B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.002 · Cited by 483
“AMPK also suppresses global protein biosynthetic capacity by reducing rRNA production (Hoppe et al., 2009).”
BackgroundAMP-activated protein kinase and its downstream transcriptional pathways
Cantó, C., & Auwerx, J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0454-z · Cited by 421
“In line with this, AMPK activation decreased RNApol I activity [46, 181].”
BackgroundInfluentialMechanisms of AMPK in the maintenance of ATP balance during energy metabolism
Ke, R., Xu, Q., Li, C., Luo, L., & Huang, D. (2018) · Cell Biology International · doi:10.1002/cbin.10915 · Cited by 414
“Hoppe et al. (2009) found that AMPK phosphorylates TIF-IA at Ser-635, which disrupts the interaction of TIF-1A with SL1, and consequently impairs the recruitment of Pol I to the rDNA promoter and transcription complex formation.”
BackgroundEnergy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L.-L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 399
AMP-Activated Protein Kinase: A Target for Drugs both Ancient and Modern
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.08.019 · Cited by 372
A Targeting Modality for Destruction of RNA Polymerase I that Possesses Anticancer Activity
Peltonen, K., Colis, L., Liu, H., Trivedi, R., Moubarek, M. S., Moore, H. M., Bai, B., Rudek, M. A., Bieberich, C. J., & Laiho, M. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.009 · Cited by 314
“Nucleolar activities are increased in cancer, and mutations of nucleolar and ribosomal proteins drive tumorigenesis (Montanaro et al., 2008; Pederson, 2011; Ruggero and Pandolfi, 2003). rRNA synthesis is commonly deregulated in cancer, by overt activation by oncogenes, like Myc, Her2/Neu; growth factor signaling pathw…”
AMP ‐activated protein kinase: a key regulator of energy balance with many roles in human disease
Grahame Hardie, D. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12268 · Cited by 285
AMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels
Hardie, D. G. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161148 · Cited by 281
Chen, S., Seiler, J., Santiago-Reichelt, M., Felbel, K., Grummt, I., & Voit, R. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.010 · Cited by 227
“Under conditions of energetic stress, AMPkinase (AMPK) phosphorylates TIF-IA at serine 635, which precludes transcription complex formation and inhibits transcription initiation (Hoppe et al., 2009).”
BackgroundMethodInfluentialSelf-citationDysregulation of the basal RNA polymerase transcription apparatus in cancer
Bywater, M. J., Pearson, R. B., McArthur, G. A., & Hannan, R. D. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3496 · Cited by 222
The nucleolus—guardian of cellular homeostasis and genome integrity
Grummt, I. (2013) · Chromosoma · doi:10.1007/s00412-013-0430-0 · Cited by 207
“AMPK-mediated phosphorylation of TIF-IA at Ser635 does not compromise binding of TIF-IA to Pol I, but abrogates the interaction between promoter-bound SL1/TIF-IB and TIF- IA, which in turn impairs transcription complex assembly (Hoppe et al. 2009).”
BackgroundInfluentialSelf-citationBasic mechanisms in RNA polymerase i transcription of the ribosomal RNA genes
Goodfellow, S. J., & Zomerdijk, J. C. B. M. (2013) · Subcellular Biochemistry · doi:10.1007/978-94-007-4525-4_10 · Cited by 197
“In support of this, Bierhoff et al. (2008) demonstrated that dephosphorylation of the CK2 target sites (serines 170 and 172) in TIF-1A (mouse RRN3) by the protein phosphatase FCP1 is required for the re-association of TIF-1A with Pol I, and hence re-initiation.”
InfluentialSharma, A., Anand, S. K., Singh, N., Dwivedi, U. N., & Kakkar, P. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113614 · Cited by 188
Keeping the home fires burning: AMP-activated protein kinase
Hardie, D. G. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0774 · Cited by 188
“Indeed, AMPK inhibits rRNA synthesis via direct phosphorylation of the key transcription factor, TIF-IA [118].”
BackgroundSalt, I. P., & Hardie, D. G. (2017) · Circulation Research · doi:10.1161/circresaha.117.309633 · Cited by 187
AMPK, metabolism, and vascular function
Rodríguez, C., Muñoz, M., Contreras, C., & Prieto, D. (2021) · The FEBS Journal · doi:10.1111/febs.15863 · Cited by 177
Chen, B.-H., Hsieh, C.-H., Tsai, S.-Y., Wang, C.-Y., & Wang, C.-C. (2020) · Scientific Reports · doi:10.1038/s41598-020-62136-2 · Cited by 167
Antioxidant and Adaptative Response Mediated by Nrf2 during Physical Exercise
Vargas-Mendoza, N., Morales-González, Á., Madrigal-Santillán, E. O., Madrigal-Bujaidar, E., Álvarez-González, I., García-Melo, L. F., Anguiano-Robledo, L., Fregoso-Aguilar, T., & Morales-Gonzalez, J. A. (2019) · Antioxidants · doi:10.3390/antiox8060196 · Cited by 162
“AMPK can block the pathway in different ways: (1) phosphorylation and inactivation of the regulatory-associated protein of mTOR (Raptor) [98]; (2) phosphorylation and activation of the negative regulator of mTORC1 tuberous sclerosis complex 2 (TSC2); (3) activation and phosphorylation of the eukaryotic elongation fact…”
MethodTargeting the AMP-Activated Protein Kinase for Cancer Prevention and Therapy
Kim, I., & He, Y.-Y. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00175 · Cited by 159
“An extensive body of evidence has demonstrated that AMPK inhibits essentially all anabolic pathways that promote cell growth, such as synthesis of fatty acid, phospholipid, protein, and ribosomal RNA synthesis (12, 13).”
BackgroundTargeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease
Curry, D. W., Stutz, B., Andrews, Z. B., & Elsworth, J. D. (2018) · Journal of Parkinson's Disease · doi:10.3233/jpd-171296 · Cited by 159
“AMPK also decreases protein synthesis by suppressing ribosomal RNA synthesis [89].”
BackgroundIntertissue Control of the Nucleolus via a Myokine-Dependent Longevity Pathway
Demontis, F., Patel, V. K., Swindell, W. R., & Perrimon, N. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.001 · Cited by 130
“…delay cellular aging and extend lifespan, such as rapamycin, AMP-activated protein kinase activity, and decreased target of rapamycin signaling, are known to reduce the size and function of the nucleolus (Grewal et al., 2007; Hoppe et al., 2009; Iadevaia et al., 2012; Zhang et al., 2000).”
InfluentialDysregulation of RNA polymerase I transcription during disease
Hannan, K. M., Sanij, E., Rothblum, L. I., Hannan, R. D., & Pearson, R. B. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.10.014 · Cited by 137
Alu element‐containing RNA s maintain nucleolar structure and function
Caudron‐Herger, M., Pankert, T., Seiler, J., Németh, A., Voit, R., Grummt, I., & Rippe, K. (2015) · The EMBO Journal · doi:10.15252/embj.201591458 · Cited by 140
“Alternatively, pre-rRNA levels were quantified by RT – qPCR as reported before (Hoppe et al , 2009).”
Self-citationEmerging roles of the neuronal nucleolus
Hetman, M., & Pietrzak, M. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.01.002 · Cited by 127
The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde?
Vara-Ciruelos, D., Russell, F. M., & Hardie, D. G. (2019) · Open Biology · doi:10.1098/rsob.190099 · Cited by 135
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
Yu, L., Chen, X., Wang, L., & Chen, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7676 · Cited by 141
“This includes downregulation of ribosomal proteins, HIF-1α, and thus expression of the glycolytic enzymes and transporters required for the Warburg effect [116, 117].”
BackgroundJaitovich, A., Angulo, M., Lecuona, E., Dada, L. A., Welch, L. C., Cheng, Y., Gusarova, G., Ceco, E., Liu, C., Shigemura, M., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.625715 · Cited by 137
“AMPK is known to down-regulate rRNA synthesis by phosphorylating the RNA polymerase I-associated transcription factor TIF-IA (57), preventing the assembly of functional transcription initiation complexes.”
BackgroundAMPK Regulation of Cell Growth, Apoptosis, Autophagy, and Bioenergetics
Paz, M. V., Cotán, D., Garrido‐Maraver, J., Oropesa-Ávila, M., de la Mata, M., Pavón, A. D., de Lavera, I., Alcocer‐Gómez, E., Álvarez-Córdoba, M., & Sánchez-Alcázar, J. A. (2016) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-319-43589-3_3 · Cited by 134
Molecular basis of Rrn3-regulated RNA polymerase I initiation and cell growth
Blattner, C., Jennebach, S., Herzog, F., Mayer, A., Cheung, A. C. M., Witte, G., Lorenzen, K., Hopfner, K.-P., Heck, A. J. R., Aebersold, R., et al. (2011) · Genes & Development · doi:10.1101/gad.17363311 · Cited by 107
Nucleolar activity in neurodegenerative diseases: a missing piece of the puzzle?
Parlato, R., & Kreiner, G. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0981-1 · Cited by 121
“By now, it is known that TIF-IA is regulated by a variety of protein kinases at distinct serine residues: ERK and RSK in response to mitogenic signals [38], S6K in response to growth stimuli [39, 40], JNK2 in response to oxidative stress [41], AMPK in response to cellular energy status [42], PERK-dependent phosphoryla…”
BackgroundMadhavi, Y. V., Gaikwad, N. B., Yerra, V. G., Kalvala, A. K., Nanduri, S., & Kumar, A. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180406120051 · Cited by 119
Regulation of rDNA transcription in response to growth factors, nutrients and energy
Kusnadi, E. P., Hannan, K. M., Hicks, R. J., Hannan, R. D., Pearson, R. B., & Kang, J. (2014) · Gene · doi:10.1016/j.gene.2014.11.010 · Cited by 117
Regulation of RNA Polymerase I Transcription in Development, Disease, and Aging
Sharifi, S., & Bierhoff, H. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012612 · Cited by 115
Self-citationGrummt, I. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07892.x · Cited by 113
Self-citationTherapeutic Targeting of Myc-Reprogrammed Cancer Cell Metabolism
Dang, C. V. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.011296 · Cited by 105
“In mammalian cells, rRNA synthesis is sensitive to glucose deprivation, which inactivates the Pol I transcription factor TIF-1A via AMPK-mediated phosphorylation (Hoppe et al. 2009).”
BackgroundAdenosine Monophosphate (AMP)-Activated Protein Kinase: A New Target for Nutraceutical Compounds
Marín-Aguilar, F., Pavillard, L., Giampieri, F., Bullón, P., & Cordero, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020288 · Cited by 98
Build-UPS and break-downs: metabolism impacts on proteostasis and aging
Ottens, F., Franz, A., & Hoppe, T. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00682-y · Cited by 108
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.03.009 · Cited by 107
Connecting the nucleolus to the cell cycle and human disease
Tsai, R. Y. L., & Pederson, T. (2014) · The FASEB Journal · doi:10.1096/fj.14-254680 · Cited by 104
The homeostatic regulation of ribosome biogenesis
Ni, C., & Buszczak, M. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.03.043 · Cited by 101
Autophagy Modulators: Mechanistic Aspects and Drug Delivery Systems
Tavakol, S., Ashrafizadeh, M., Deng, S., Azarian, M., Abdoli, A., Motavaf, M., Poormoghadam, D., Khanbabaei, H., Afshar, E. G., Mandegary, A., et al. (2019) · Biomolecules · doi:10.3390/biom9100530 · Cited by 98
“phase cell cycle arrest and p53 activation are induced [74].”
BackgroundSalminen, A., Kaarniranta, K., & Kauppinen, A. (2016) · Biogerontology · doi:10.1007/s10522-016-9655-7 · Cited by 95
“Given that AMPK signaling can inhibit ribosomal RNA synthesis (Hoppe et al. 2009), this might repress the HIF-1a-induced response to hypoxia.”
Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA
Nguyen, L. X. T., & Mitchell, B. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313097110 · Cited by 96
miR‐424‐5p reduces ribosomal RNA and protein synthesis in muscle wasting
Connolly, M., Paul, R., Garros, R. F., Natanek, S. A., Bloch, S. A. A., Lee, J. Y., Lorenzo, J. P., Patel, H. P., Cooper, C. C., Sayer, A. A., et al. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12266 · Cited by 92
“sizing ribosomes is therefore energetically expensive, and as a result, the rate of ribosome synthesis is tightly regulated to optimize ribosomal content for the current conditions.(6,7)”
Duszka, K., Gregor, A., Guillou, H., König, J. S., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071708 · Cited by 90
Ghosh, S., Dent, R., Harper, M.-E., Gorman, S. A., Stuart, J. S., & McPherson, R. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-56 · Cited by 83
“This observation is consistent with a recent report that links ribosomal RNA synthesis to cellular energy supply through activation of the AMP-activated protein kinase [ 35 ].”
ResultWeisová, P., Dávila, D., Tuffy, L. P., Ward, M. W., Concannon, C. G., & Prehn, J. H. M. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3544 · Cited by 89
“…B, and may have effects on transcription complex formation by adapting rRNA synthesis to changes in cellular energy availability (29, 32, 52, 71, 118) ( The adenylate kinase reaction (2 ADP $ ATP þ AMP) is in close equilibrium, making the resultant AMP:ATP ratio a more sensitive…”
Missiaen, R., Lesner, N. P., & Simon, M. C. (2023) · The EMBO Journal · doi:10.15252/embj.2022112067 · Cited by 83
“Importantly, AMPK inhibits ribosomal RNA synthesis, which represses the HIF-1 a mediated hypoxia stress response (Hoppe et al , 2009).”
Muhammed Jamsheer, K., Kumar, M., & Srivastava, V. (2021) · Journal of Experimental Botany · doi:10.1093/jxb/erab079 · Cited by 79
Multifaceted Role of AMPK in Viral Infections
Bhutta, M., Gallo, E. S., & Borenstein, R. (2021) · Cells · doi:10.3390/cells10051118 · Cited by 78
“AMPK inhibits ribosomal RNA synthesis by phosphorylating and inhibiting the RNA-polymerase I-associated transcription initiation factor IA (TIF-IA) at Ser-635 [63] and inhibits protein elongation by phosphorylating and activating eukaryotic elongation factor 2 kinase (eEF2K) [64].”
BackgroundNucleolus and Nucleolar Stress: From Cell Fate Decision to Disease Development
Hua, L., Yan, D., Wan, C., & Hu, B. (2022) · Cells · doi:10.3390/cells11193017 · Cited by 77
“Nutrient deprivation may cause rapid phosphorylation of TIF-IA at S635 residue by AMPK, leading to the inactivation of TIF-IA and the shutdown of rRNA transcription [44].”
BackgroundRegulation of energy homeostasis by the ubiquitin-independent REGγ proteasome
Sun, L., Fan, G., Shan, P., Qiu, X., Dong, S., Liao, L., Yu, C., Wang, T., Gu, X., Li, Q., et al. (2016) · Nature Communications · doi:10.1038/ncomms12497 · Cited by 71
“The TBP-TAFI complex SL1, transcription activator UBF and the RNA polymerase I (Pol I) enzyme with associated factors such as TIF1A and TIF-IC form the minimal complex required for rDNA transcription 16–19 .”
Zhao, Z., Dammert, M. A., Hoppe, S., Bierhoff, H., & Grummt, I. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw496 · Cited by 76
Self-citationCao, Y., Bojjireddy, N., Kim, M., Li, T., Zhai, P., Nagarajan, N., Sadoshima, J., Palmiter, R. D., & Tian, R. (2017) · Circulation Research · doi:10.1161/circresaha.117.311159 · Cited by 74
“Furthermore, AMPK substrates have been identified in the nucleus, but the isoform specificity of nuclear AMPK has been poorly understood.(18,19) To determine the isoform-specific role of the AMPK, here we created cellular and mouse models in which the total AMPK activity was kept unaltered but the complex contained on…”
The crosstalk between metabolism and translation
Biffo, S., Ruggero, D., & Santoro, M. M. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.022 · Cited by 72
Regulation of Ribosomal Gene Expression in Cancer
Nguyen, L. X. T., Raval, A., Garcia, J. S., & Mitchell, B. S. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24854 · Cited by 68
“In addition to regulating chromatin structure, UBF also cooperates with the promoter selectivity factor (SL1) complex in formation of a pre-initiation complex at active JOURNAL OF CELLULAR PHYSIOLOGY rDNA gene promoters (Fig.”
BackgroundInfluentialRemodelling of the translatome controls diet and its impact on tumorigenesis
Yang, H., Zingaro, V. A., Lincoff, J., Tom, H. J., Oikawa, S., Osés-Prieto, J. A., Edmondson, Q. D., Seiple, I. B., Shah, H., Kajimura, S., et al. (2024) · Nature · doi:10.1038/s41586-024-07781-7 · Cited by 66
Tanaka, Y., Yano, H., Ogasawara, S., Yoshioka, S.-I., Imamura, H., Okamoto, K., & Tsuneoka, M. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00579-15 · Cited by 65
“It has been reported that activation of AMPK by glucose starvation reduced the amount of TIF-IA recruited to the rDNA promoter and reduced rRNA transcription (22), which we confirmed in the presence of 10 mM 2DG (Fig.”
BackgroundInfluentialMesquita, P. H. C., Vann, C. G., Phillips, S. M., McKendry, J., Young, K. C., Kavazis, A. N., & Roberts, M. D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.725866 · Cited by 62
AMPK at the interface of nutrient sensing, metabolic flux and energy homeostasis
Smith, T. K. T., Townsend, L. K., Smiles, W. J., Oakhill, J. S., Fullerton, M. D., & Steinberg, G. R. (2026) · Nature Metabolism · doi:10.1038/s42255-025-01442-3 · Cited by 66
“Similar observations were reported with Pol I-mediated transcription, where AMPK activity inhibits rRNA synthesis 165 .”
Hardie, D. G. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010819 · Cited by 55
“AMPK activation causes a p53-dependent cell cycle arrest (Imamura et al. 2001) and inhibits essentially all biosynthetic pathways required for cell growth, including synthesis of fatty acids, phospholipids, proteins, and ribosomal RNA (Hardie 2007; Hoppe et al. 2009).”
BackgroundYang, X., Wang, H., Huang, C. S., He, X., Xu, W., Luo, Y., & Huang, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-14868-x · Cited by 61
Yang, L., Song, T., Chen, L., Kabra, N., Zheng, H., Koomen, J., Seto, E., & Chen, J. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00476-13 · Cited by 50
“A low ATP level activates AMP-activated protein kinase (AMPK), which phosphorylates Pol I-associated transcription factor TIF-1A and inhibits the assembly of the active transcription initiation complex (27).”
BackgroundRibosome biogenesis in skeletal muscle: coordination of transcription and translation
von Walden, F. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00963.2018 · Cited by 56
Pharmacological Manipulation of Translation as a Therapeutic Target for Chronic Pain
Yousuf, M. S., Shiers, S. I., Sahn, J. J., & Price, T. J. (2020) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000030 · Cited by 55
“, 2018), ribosomal RNA synthesis (Hoppe et al., 2009), and translation elongation (Deng et al.”
BackgroundAMPK pathway: an emerging target to control diabetes mellitus and its related complications
Kakoti, B. B., Alom, S., Deka, K., & Halder, R. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01420-8 · Cited by 54
“In addition to inhibiting mTOR, AMPK has been shown to reduce protein synthesis by inhibiting TIF-IA, a transcription factor for RNA-polymerase I, and blocking ribosomal RNA synthesis by phosphorylation [162].”
Furuhagen, S., Liewenborg, B., Breitholtz, M., & Gorokhova, E. (2014) · Environmental Science & Technology · doi:10.1021/es5044722 · Cited by 49
RNA Mimicry by the Fap7 Adenylate Kinase in Ribosome Biogenesis
Loc'h, J., Blaud, M., Réty, S., Lebaron, S., Deschamps, P., Bareille, J., Jombart, J., Robert‐Paganin, J., Delbos, L., Chardon, F., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001860 · Cited by 52
“The AMP-activated protein kinase (AMPK) monitors nutrient availability and cellular energy status, through the AMP/ATP ratio, and regulates rRNA transcription, but is otherwise unrelated to Fap7 [39,40].”
BackgroundLKB1 tumor suppressor: Therapeutic opportunities knock when LKB1 is inactivated
Zhou, W., Zhang, J., & Marcus, A. I. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.06.002 · Cited by 51
“More recently, AMPK was found to directly phosphorylate TIF-IA at Ser-635, which disrupts the interaction of TIF-IA with transcription factor SL1 and prevents the assembly of the transcriptional initiation complex.(50) This evidence indicated that AMPK is also a negative regulator of pre-rRNA synthesis.”
BackgroundAMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
Dandapani, M., & Hardie, D. G. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120351 · Cited by 52
Regulation of ribosomal RNA synthesis in T cells: requirement for GTP and Ebp1
Nguyen, L. X. T., Lee, Y., Urbani, L. J., Utz, P. J., Hamburger, A. W., Sunwoo, J. B., & Mitchell, B. S. (2015) · Blood · doi:10.1182/blood-2014-12-616433 · Cited by 51
Tumurbaatar, I., Cizmecioglu, O., Hoffmann, I., Grummt, I., & Voit, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014711 · Cited by 51
“Cdc14 transcripts were measured by reverse transcription using random hexamer primers and quantitative real-time PCR (LightCycler 480, Roche) essentially as described [46].”
MethodSelf-citationKorponay, T. C., Balnis, J., Vincent, C. E., Singer, D. V., Chopra, A., Adam, A. P., Ginnan, R. G., Singer, H. A., & Jaitovich, A. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0061oc · Cited by 51
AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules
Tarasiuk, O., Miceli, M., Domizio, A. D., & Nicolini, G. (2022) · Biology · doi:10.3390/biology11071041 · Cited by 49
“AMPK downregulates ribosomal RNA synthesis by inducing the inhibitory phosphorylation of transcription initiation factor 1A [29,30].”
Viruses and the fuel sensor: the emerging link between AMPK and virus replication
Mankouri, J., & Harris, M. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.687 · Cited by 49
“Once activated, AMPK phosphorylates multiple substrate proteins to effect a general inhibition of anabolic (ATP‐consuming) metabolic pathways [7,38] (4) and a simultaneous activation of catabolic (ATP‐generating) pathways [7,39] (5), restoring ATP levels.”
BackgroundHow Cancer Exploits Ribosomal RNA Biogenesis: A Journey beyond the Boundaries of rRNA Transcription
Gaviraghi, M., Vivori, C., & Tonon, G. (2019) · Cells · doi:10.3390/cells8091098 · Cited by 47
“This unbalance activates the AMP-activated protein kinase (AMPK) that directly phosphorylates TIF-IA on S635, hampering its binding to the SL1 complex and thus its ability to bridge the PIC-PolI interaction (Figure 1A) [38].”
BackgroundAMPK as a Pro-longevity Target
Burkewitz, K., Weir, H. J. M., & Mair, W. B. (2016) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-319-43589-3_10 · Cited by 47
DYNAMIC ANALYSIS OF FALLING WEIGHT DEFLECTOMETER DATA
Sebaaly, B. E., Mamlouk, M. S., & Davies, T. G. (1986) · Transportation Research Record Journal of the Transportation Research Board · Cited by 45
You, M., Kim, H.-J., Kook, J., & Kim, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040966 · Cited by 44
“AMPK essentially inhibits all anabolic pathways that promote cell growth [8].”
BackgroundAMP-Activated Protein Kinase: Friend or Foe in Cancer?
Vara‐Ciruelos, D., Dandapani, M., & Hardie, D. G. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033619 · Cited by 43
“…synthetase 1 (Qian et al. 2018); ( f ) ribosomal RNA synthesis, via phosphorylation of the RNA polymerase 1 transcription factor TIF-1A (Hoppe et al. 2009); and (g) protein synthesis, in part via inhibition of mTOR complex 1 (mTORC1) by phosphorylation of its upstream regulator TSC2…”
BackgroundGradual reduction in rRNA transcription triggers p53 acetylation and apoptosis via MYBBP1A
Kumazawa, T., Nishimura, K., Katagiri, N., Hashimoto, S., Hayashi, Y., & Kimura, K. (2015) · Scientific Reports · doi:10.1038/srep10854 · Cited by 43
Solsona, R., Pavlin, L., Bernardi, H., & Sanchez, A. M. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052741 · Cited by 43
Impaired rRNA synthesis triggers homeostatic responses in hippocampal neurons
Kiryk, A., Sowodniok, K., Kreiner, G., Parkitna, J. M. R., Soenmez, A., Górkiewicz, T., Bierhoff, H., Wawrzyniak, M., Janusz, A., Liss, B., et al. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00207 · Cited by 41
“As such TIF-IA activity is differentially regulated by various kinases including mTOR, ERK, AMPK, JNK (Zhao et al., 2003; Mayer et al., 2004, 2005; Hoppe et al., 2009) in response to environmental changes.”
BackgroundSelf-citationHepatic rRNA Transcription Regulates High-Fat-Diet-Induced Obesity
Oie, S., Matsuzaki, K., Yokoyama, W., Tokunaga, S., Waku, T., Han, S., Iwasaki, N., Mikogai, A., Yasuzawa-Tanaka, K., Kishimoto, H., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.038 · Cited by 41
“AMPK activation represses rRNA transcription in a TIF-IA phosphorylation-dependent manner in cultured cells (Hoppe et al., 2009).”
BackgroundDuszka, K., & Wahli, W. (2020) · Nutrients · doi:10.3390/nu12113476 · Cited by 40
“Furthermore, AMPK reduces protein synthesis by inhibiting mTOR [155].”
BackgroundNovel Nucleolar Pathway Connecting Intracellular Energy Status with p53 Activation
Kumazawa, T., Nishimura, K., Kuroda, T., Ono, W., Yamaguchi, C., Katagiri, N., Tsuchiya, M., Masumoto, H., Nakajima, Y., Murayama, A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.209916 · Cited by 39
Targeting AMPK Signaling in the Liver: Implications for Obesity and Type 2 Diabetes Mellitus
Liu, Y., Wang, D., & Yang, L. (2022) · Current Drug Targets · doi:10.2174/1389450123666220429082702 · Cited by 38
Immunometabolic cross-talk in the inflamed heart
Marelli‐Berg, F. M., & Aksentijević, D. (2019) · Cell Stress · doi:10.15698/cst2019.08.194 · Cited by 37
“For example, HIF1α activates aerobic glycolysis, an effect which is counteracted by AMPK activation [241] possibly via inhibition of protein synthesis [242].”
BackgroundAMPK allostery: A therapeutic target for the management/treatment of diabetic nephropathy
Ayinde, K. S., Olaoba, O. T., Boyenle, I. D., Du, L., Lü, Q., Yin, X., & Adelusi, T. I. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118455 · Cited by 37
Sunamura, E.-I., Konno, H., Imashimizu, M., Sugano, Y., & Hisabori, T. (2010) · Plant and Cell Physiology · doi:10.1093/pcp/pcq061 · Cited by 37
“In the case of eukaryotic cells including photosynthetic plants, the intracellular AMP/ATP ratio is known to be an important signal which controls various metabolic pathways ( Hoppe et al. 2009 ).”
Background
Metadata
- Authors
- Hoppe, S., Bierhoff, H., Cado, I., Weber, A., Tiebe, M., Grummt, I., & Voit, R.
- Affiliations
- German Cancer Research Center (DE)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-10-20
- Volume
- 106
- Issue
- 42
- Pages
- 17781-17786
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2764937
- OpenAlex
- W2166025848
- Cited by
- 225
- References
- 36
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 7 · 2023: 9 · 2022: 15 · 2021: 26 · 2020: 14 · 2019: 12 · 2018: 10 · 2017: 12 · 2016: 19 · 2015: 14 · 2014: 17 · 2013: 16 · 2012: 9
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- AMPK, ribosomal RNA synthesis, RNA polymerase I, TIF-IA, glucose restriction, cellular energy status, nutrient availability, energy homeostasis
- MeSH terms
- Adenosine Triphosphate, Animals, Cell Line, Energy Metabolism, Glucose, Humans, Models, Biological, Phosphorylation, Recombinant Proteins, RNA Polymerase I, RNA, Ribosomal, Serine, Transcription, Genetic, Pol1 Transcription Initiation Complex Proteins, NIH 3T3 Cells, Mice, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.